| The prevalence of BRCA1 mutations among young women with triple-negative breast cancer SR Young, RT Pilarski, T Donenberg, C Shapiro, LS Hammond, J Miller, ... BMC cancer 9, 1-5, 2009 | 319 | 2009 |
| Rho GTPases: Anti-or pro-neoplastic targets? I Zandvakili, Y Lin, JC Morris, Y Zheng Oncogene 36 (23), 3213-3222, 2017 | 96 | 2017 |
| Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma MR Akbari, R Malekzadeh, D Nasrollahzadeh, D Amanian, F Islami, S Li, ... Oncogene 27 (9), 1290-1296, 2008 | 94 | 2008 |
| Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes G Calderon, A McRae, J Rievaj, J Davis, I Zandvakili, S Linker-Nord, ... EBioMedicine 55, 2020 | 59 | 2020 |
| Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort CV Schneider, I Zandvakili, CA Thaiss, KM Schneider JHEP Reports 3 (3), 100263, 2021 | 53 | 2021 |
| Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: a second experience I Zandvakili, CB Conboy, AO Ayed, EJ Cathcart‐Rake, A Tefferi American journal of hematology 93 (5), E123-E125, 2018 | 51 | 2018 |
| Association of statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality MS Vell, R Loomba, A Krishnan, KJ Wangensteen, J Trebicka, KT Creasy, ... JAMA Network Open 6 (6), e2320222-e2320222, 2023 | 32 | 2023 |
| A genome-first approach to mortality and metabolic phenotypes in MTARC1 p. Ala165Thr (rs2642438) heterozygotes and homozygotes CV Schneider, KM Schneider, DM Conlon, J Park, M Vujkovic, I Zandvakili, ... Med 2 (7), 851-863. e3, 2021 | 29 | 2021 |
| Germline RAP80 mutations and susceptibility to breast cancer MR Akbari, P Ghadirian, A Robidoux, M Foumani, Y Sun, R Royer, ... Breast cancer research and treatment 113, 377-381, 2009 | 29 | 2009 |
| Dietary vitamin E intake is associated with a reduced risk of developing digestive diseases and nonalcoholic fatty liver disease E Scorletti, KT Creasy, M Vujkovic, M Vell, I Zandvakili, DJ Rader, ... Official journal of the American College of Gastroenterology| ACG 117 (6 …, 2022 | 19 | 2022 |
| Loss of RhoA exacerbates, rather than dampens, oncogenic K-Ras induced lung adenoma formation in mice I Zandvakili, AK Davis, G Hu, Y Zheng PLoS One 10 (6), e0127923, 2015 | 18 | 2015 |
| Systematic review and meta-analysis: efficacy of vancomycin taper and pulse regimens in Clostridioides difficile infection K Sehgal, I Zandvakili, R Tariq, DS Pardi, S Khanna Expert review of anti-infective therapy 20 (4), 577-583, 2022 | 11 | 2022 |
| Cell-free DNA testing: future applications in gastroenterology and hepatology I Zandvakili, KN Lazaridis Therapeutic Advances in Gastroenterology 12, 1756284819841896, 2019 | 9 | 2019 |
| 380 Reimann F, Gedulin B, Vella A, LaRusso NF, Camilleri M, Gribble FM, and Acosta A G Calderon, A McRae, J Rievaj, J Davis, I Zandvakili, S Linker-Nord, ... Ileo-colonic delivery 387, 0 | 5 | |
| A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipids CV Schneider, L Hehl, KT Creasy, C Vitali, MS Vell, M Vujkovic, J Park, ... Alimentary Pharmacology & Therapeutics 58 (2), 238-249, 2023 | 4 | 2023 |
| Aspirin is associated with a reduced incidence of liver disease in men MS Vell, A Krishnan, K Wangensteen, M Serper, KS Seeling, L Hehl, ... Hepatology Communications 7 (10), e0268, 2023 | 3 | 2023 |
| A phenotypic approach to obesity treatment I Zandvakili, M Pulaski, O Pickett‐Blakely Nutrition in Clinical Practice 38 (5), 959-975, 2023 | 3 | 2023 |
| Large-scale identification of undiagnosed hepatic steatosis using natural language processing CV Schneider, T Li, D Zhang, AI Mezina, P Rattan, H Huang, KT Creasy, ... EClinicalMedicine 62, 2023 | 3 | 2023 |
| Hepatitis, pancreatitis and rash in a patient with chronic lymphocytic leukemia I Zandvakili, JW Lloyd, KV Giridhar Gastroenterology 157 (4), e8-e9, 2019 | 3 | 2019 |
| A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids L Hehl, KT Creasy, C Vitali, E Scorletti, KS Seeling, MS Vell, MD Rendel, ... Hepatology Communications 8 (5), e0427, 2024 | 1 | 2024 |
Carolin Victoria Schneider, MDAssistant Professor, PI在 pennmedicine.upenn.edu 的电子邮件经过验证
